Blockchain Registration Transaction Record

Graphene Quantum Dots Show Promise Against Parkinson's Protein Clumps

Graphene quantum dots (GQDs) interfere with alpha-synuclein aggregation linked to Parkinson's and MSA, as shown in a new STAM study. Intranasal GQDs reduce toxic protein clumps and activate autophagy in mice, offering a promising direction for neurodegenerative disease therapies.

This discovery matters because neurodegenerative diseases like Parkinson's and multiple system atrophy affect millions worldwide, with no current treatments that stop disease progression. If graphene quantum dots can be safely developed into therapies, they could offer a way to directly target the root cause of these conditions—protein aggregation—rather than just managing symptoms. This opens a new avenue for research into nanomaterial-based treatments that might also apply to other diseases involving toxic protein buildup, such as Alzheimer's or Huntington's.